By publicly releasing the software, which includes Fujitsu-developed algorithms, as open-source software, Fujitsu aims to accelerate the practical adoption of quantum software and contribute to ...

For years, quantum was something most people encountered in documentaries, or late-night debates about Schrödinger’s cat. Today, it’s also becoming a career. Companies are hiring now, salaries are ...

Quantum computing is no longer a field that exists only in research papers. Companies are hiring, salaries are rising, and the roles themselves are becoming more defined. According to QED-C’s State of ...

One of physicists’ foundational assumptions is that atoms aren’t unique—if two atoms have the same number of protons, neutrons and electrons, they will look and act exactly alike. This belief is ...

The Ariel Motor Company has always put performance first, and its latest iteration of the iconic Atom turns the volume way up. Officially known as the Ariel Atom 4RR, the newest member of the Atom ...

Claude Code Python Porting Workspace The primary src/ tree in this repository is now dedicated to Python porting work. The March 31, 2026 Claude Code source exposure is part of the project's ...

With a Thunderbolt cable the EX20 proved an good performer. With the bundled cable, not so much, though this may be a firmware issue. A great external drive, but wait for the issue to resolve — or use ...

Neutral-atom arrays are a rapidly emerging platform to create quantum computers. In a foundational study led by graduate students Aaron Holman and Yuan Xu from the Will and Yu labs, respectively, the ...

Not tunable. Hearing support is very blunt. Not a great value considering the whole package. Audien has repeatedly tried again in this low-end part of the market, cranking out at least five models of ...

Hub for quantum advances grows as additional companies move in The Colorado Quantum Incubator (COQI)—a CU Boulder-led hub for advancing quantum lab-to-market technology translation, research, ...

Atom Therapeutics is touting data from a phase 2b/3 study as evidence that its gout drug has the efficacy and safety profile to stand out from the competition. The Chinese biotech evaluated the oral ...

ATOM rebounds 2.6% in 23-hour swing, recovering from a sharp drop to $4.13 with a rally back to $4.24, supported by strong buying near the $4.15 level. Trading volume surges to $4.38M, far exceeding ...